Specify a stock or a cryptocurrency in the search bar to get a summary
Truscreen Ltd
TRUTruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand. Address: Equitable House, Auckland, New Zealand, 1010
Analytics
WallStreet Target Price
11.39 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TRU
Dividend Analytics TRU
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TRU
Stock Valuation TRU
Financials TRU
Results | 2019 | Dynamics |